9 interventions in Emerging Therapy.
Hyperbaric Oxygen Therapy (HBOT)
A widely marketed 'age-reversal' therapy built on one small uncontrolled study of surrogate markers from a group that runs commercial clinics. The telomere findings are interesting but unreplicated and unlinked to any health outcome. Be skeptical of clinics charging tens of thousands citing this single paper as proof of rejuvenation.
Mitochondrial Transfer / Transplantation
Real, careful science exists for a narrow ischemia indication, but 'mitochondrial transplant to reverse aging' is essentially theoretical, with no human aging data and unsolved problems of delivery, persistence, and immunogenicity. Any consumer 'mitochondrial therapy' for aging is far ahead of the evidence.
Partial Reprogramming (Yamanaka Factors)
Scientifically the most exciting frontier in rejuvenation, and it has just crossed into humans: the FDA cleared the first OSK gene therapy in January 2026. But that trial is for an eye disease and has no results, mouse lifespan data is the only efficacy evidence, and the cancer risk is real. 'Proven to reverse human aging' is false; 'the frontier just opened its first human trial' is the honest read. Any clinic selling 'reprogramming' rejuvenation today is selling something unproven and potentially dangerous.
Thymus Regeneration (TRIIM)
A genuinely intriguing first human hint that epigenetic age might be reversible and the thymus regrown, widely publicized. But it is 9 people, no control group, and the reversal may reflect growth hormone/metformin rather than thymic rejuvenation. Growth hormone carries real risks. Await the controlled trial before believing the headline.
Epitalon (Epithalon)
Promoted in biohacker circles on the strength of unreplicated, low-quality single-lab studies, sold as an unregulated injectable. There is no credible independent human evidence it does anything for aging. This is at the far speculative end: high hype, minimal legitimate science, real sourcing risk.
Exosomes
A legitimate and promising research vehicle for cell-free signaling therapy that has been prematurely commercialized into unregulated IV, injected, and 'facial' exosome products sold for rejuvenation with zero efficacy evidence and documented infection harms drawing FDA warnings. The biology is real; the marketplace offerings are unproven and unsafe.
Gene Therapy (Follistatin, Telomerase/TERT)
Compelling mouse biology, but human 'evidence' consists of a founder's uncontrolled self-experiment and marketing by offshore biohacking ventures selling injections with no trials, no safety data, and a plausible cancer risk. Anyone offering follistatin or telomerase gene therapy for aging today is operating far outside validated medicine. Extreme skepticism warranted.
Plasma Dilution / Young Plasma
A vivid mouse phenomenon that spawned a predatory clinic industry selling young-blood infusions for thousands of dollars with zero human efficacy evidence, drawing an explicit FDA warning. The more interesting science (dilution/removal of bad factors) is still preclinical. Treat any young-plasma 'longevity' offering as a red-flag scam.
Stem Cell Therapies
A legitimate research area for specific diseases that has been aggressively hijacked by predatory clinics selling IV or injected 'stem cells' for anti-aging with no efficacy evidence and real, sometimes catastrophic, harms. Frontier, a site we also run, covers one example of that legitimate side: manufactured islet cells reversing type 1 diabetes in a first trial. There is no proven stem-cell therapy for aging itself. This is one of the highest-risk areas for consumer exploitation.